Johnson & Johnson’s COVID-19 vaccine is being pulled from the market over safety concerns. As it turns out, the Food and Drug Administration did this without warning the Biden administration.
The FDA halted distribution of J&J’s coronavirus vaccine after six patients developed a clotting disorder within weeks of getting inoculated, Fox News reported. To date, 6.8 million people have already been dosed with the single-shot vaccine.
As of 4/12, 6.8m+ doses of the J&J vaccine have been administered in the U.S. CDC & FDA are reviewing data involving 6 reported U.S. cases of a rare & severe type of blood clot in individuals after receiving the vaccine. Right now, these adverse events appear to be extremely rare
— U.S. FDA (@US_FDA) April 13, 2021
“We were notified last night there would be an announcement in the morning,” Jeff Zients, White House Coronavirus Task Force coordinator, said Tuesday. Although the Centers for Disease Control and Prevention called the side effects “extremely rare,” the organization is planning to meet Wednesday with the Advisory Committee on Immunization Practices.
“We have more than enough supply of Pfizer and Moderna to continue the current pace of 3 million shots per day,” Zients reassured the public. The company’s coronavirus vaccine was the third to be given emergency use authorization, although it’s the only option that is done in a single dose. So far, over 74 million people have been fully vaccinated.
The J&J vaccine is thought to have caused cerebral venous sinus thrombosis. a specific and dangerous type of clot in the brain. Experts believe the immune response activated by the vaccine causes a dangerous combination of low platelets and blood clots, complicating treatment that usually includes blood thinners.
The victims were all women ages 18 to 48, although officials are careful to convey that the relatively small group of patients doesn’t indicate a pattern. So far, one of the women has died while another remains in critical condition.
The COVID-19 vaccines are new pharmaceutical products. It’s difficult to know what the long-term effects will be considering that they were developed and brought to market in less than a year‘s time.
However, it’s also noteworthy that such a decision was abruptly handed down by the FDA after only six cases of that serious side effect were reported. Only time will tell whether the cure is worse than the disease when it comes to these hastily-executed and minimally-researched vaccines.